NanoViricides (NYSE: NNVC) reported Q1 EPS of $0.00, versus ($0.04) reported last year. Loss from operations narrower from $1.89 million down to $1.69 million.

For earnings history and earnings-related data on NanoViricides (NNVC) click here.